Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies 
BP Nears $10 Billion Castrol Stake Sale to Stonepeak 
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions 
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 
Italy Fines Apple €98.6 Million Over App Store Dominance 
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program 
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project 
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling 
MINNEAPOLIS, April 01, 2016 -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to present at the 15th Annual Needham Healthcare Conference in New York on Tuesday, April 12th at 5:00pm (EDT).
Phil Nalbone, VP of Corporate Development of Vascular Solutions, will deliver the Company’s presentation. To hear the live audio webcast of the Vascular Solutions’ presentation, go to the investor relations page of the Company’s web site www.vasc.com and click on the “Investor Conferences” icon a few minutes prior to start time to download any necessary software.
About Needham Company, LLC
Needham & Company, LLC, a wholly owned subsidiary of The Needham Group, Inc., is a privately held, full-service investment bank that has focused exclusively on growth companies since its founding 31 years ago. It provides its clients with the resources to achieve their financing and strategic objectives. The Firm has capital raising expertise in IPOs, follow-on public equity offerings, confidentially marketed equity offerings, private placements, and in mergers and acquisitions, and corporate and venture services (including share repurchases). In addition to investment banking, Needham & Company LLC’s activities include institutional sales and trading, and asset management. To serve its institutional clients, Needham & Company, LLC produces comprehensive equity research on more than 325 companies in communications and enterprise infrastructure; healthcare; industrial technology; Internet, entertainment and consumer; semiconductors and semiconductor equipment; and software and services, and makes a market in over 600 stocks. The Firm is headquartered in New York City with offices in Boston, MA; Chicago, IL; Menlo Park, CA; and San Francisco, CA. Needham & Company, LLC is a member of FINRA & SIPC. For more information, please visit www.needhamco.com.
About Vascular Solutions
Vascular Solutions, Inc. is an innovative medical device company that focuses on developing unique clinical solutions for coronary and peripheral vascular procedures. The company’s product line consists of more than 100 products and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists, and vein specialists through its direct U.S. sales force and international independent distributor network.
Contact: Phil Nalbone, VP Vascular Solutions, Inc. (763) 656-4300
